Enliven Therapeutics Overview
Enliven Therapeutics Target Price
Analysts' 12-month price predictions for ELVN.
Get informed when a big investor buys or sells
+ FollowShare Price
$48.6
Average Target Price
$65.25
34.3% upside
34.3% upside4 analysts in the last 4 months
High: $80 | Low: $59
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-08 | Stifel Nicolaus | $60 | 23.5% upside |  |
| 2026-06-02 | Mizuho SecuritiesSalim Syed | $62 | 27.6% upside | |
| 2026-05-12 | Guggenheim | $80 | 64.6% upside | |
| 2026-05-08 | Goldman Sachs | $59 | 21.4% upside | |
| 2025-06-16 | Robert W. BairdColleen Kusy | $52 | 7% upside | |
| 2025-03-21 | H.C. Wainwright | $39 |  19.8% downside | |
| 2024-11-15 | Robert W. BairdColleen Kusy | $40 | 17.7% downside | |
| 2024-09-23 | Mizuho SecuritiesSalim Syed | $39 | 19.8% downside | |
| 2024-06-10 | Robert W. BairdColleen Kusy | $32 | 34.2% downside | |
| 2024-04-09 | Mizuho SecuritiesSalim Syed | $34 | 30% downside | |